Papaverine, a selective PDE10A inhibitor rectified behavioral phenotypes associated with ADHD, possibly by altering the protein markers associated with neuronal survival, neuronal transcription factor, brain inflammation, and brain oxidative stress. Implicating PDE10A as a possible target for furthering our understanding of ADHD phenotypes. The gene discussed is PDE10A; the disease is attention deficit-hyperactivity disorder.